Critical Evaluation of the Specificity and Sensitivity of Liver Imaging

Zakim and Boyer's Hepatology

Volumn , Issue , 2006, Pages 251-289

  Aslam, Rizwan ^a   Sun, Yee Li ^a   Yee, Judy ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882876494     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3258-8.50020-6     Document Type: Chapter

References (125)

1. Golli M, Van Nhieu JT, Mathieu D, et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994, 190:741-744.
2. Grazioli L, Federle MP, Brancatelli G, et al. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001, 21:877-894.
3. Mortele KJ, Ros PR Benign liver neoplasms. Clin Liver Dis 2002, 6:119-145.
4. Arrive L, Flejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proven lesions. Radiology 1994, 193:507-512.
5. Chung KY, Mayo-Smith WW, Saini S, et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. Am J Roentgenol 1995, 165:303-308.
6. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT and pathologic analysis. Radiographics 2004, 24:3-19.
7. Brancatelli G, Federle MP, Grazioli L, et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001, 219:61-68.
8. Gabata T, Kadoya M, Matsui O, et al. Biliary cystadenoma with mesenchymal stroma of the liver: Correlation between unusual MR appearance and pathologic findings. J Magn Reson Imag 1998, 8:503-504.
9. Sada PN, Ramakrishna B Computed tomography of von Meyenburg complex simulating microabscesses. Australas Radiol 1994, 38:225-226.
10. Eisenberg D, Hurwitz L, Yu A. CT and sonography of multiple bile duct hamartomas simulating malignant disease. Am J Roentgenol 1986, 147:279-280.
11. Horton KM, Bluemke DA, Hruban RH, et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999, 19:431-451.
12. Trotter JF, Everson GT Benign focal lesions of the liver. Clin Liver Dis 2001, 5:17-42.
13. Leslie DF, Johnson CD, MacCarty RL, et al. Single-pass CT of hepatic tumors: Value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. Am J Roentgenol 1995, 165:1403-1406.
14. Nino-Murcia M, Olcott EW, Jeffrey RB, et al. Focal liver lesions: Pattern-based classification scheme for enhancement at arterial phase. CT Radiology 2000, 215:746-751.
15. Tsai CC, Yen TC, Tzen KY The value of Tc-99m red blood cell SPECT in differentiating giant cavernous hemangioma of the liver from other liver solid masses. Clin Nucl Med 2002, 27:578-581.
16. Hogemann D, Flemming P, Kreipe H, Galanski M. Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 2001, 11:1389-1395.
17. Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 1999, 23:34-48.
18. Mortele KJ, Wiesner W, deHemptinne B, et al. Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. Radiology 2002, 12:304-308.
19. Young ST, Paulson EK, Washington K, et al. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994, 163:1385-1388.
20. Zweibel WJ Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR 1995, 16:8-15.
21. Jones EC, Chezmar JL, Nelson RC, Bernardino ME The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. Am J Roentgenol 1992, 158:535-539.
22. Soyer P, Levesque M, Elias D, et al. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 1992, 183:541.
23. Soyer P, Bluemke DA, Fishman EK CT during arterial portography for the preoperative evaluation of hepatic tumors: How, when, and why?. Am J Roentgenol 1994, 163:1325-1331.
24. Sica GT, Ji H, Ros PR CT and MR imaging of hepatic metastases. Am J Roentgenol 2000, 174:691-698.
25. Kelekis NL, Semelka RC, Woosley JT Malignant lesions of the liver with high signal intensity on T1 weighted MR images. J Magn Reson Imag 1996, 6:291-294.
26. Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: Comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imag 1997, 7:1040-1047.
27. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996, 198:881-887.
28. Gallez B, Bacic G, Swartz HM Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 1996, 35:14-19.
29. Valls C, Andía E, Sánchez A, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001, 218:55.
30. Ward J, Naik KS, Guthrie JA, et al. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999, 210:459.
31. Kuszyk BS, Bluemke DA, Urban BA, et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. Am J Roentgenol 1996, 166:91-95.
32. Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging PET): a meta-analysis. Radiology 2002, 224:748-756.
33. Itola JV, Delbeke D, Sandler MP, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996, 171:21-26.
34. Boykin KN, Zibari GB, Lilien DL, et al. The use of FDG-positron emission tomography for the evaluation of colorectal metastases to the liver. Am Surg 1999, 65:1183-1185.
35. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003, 44:1200-1209.
36. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas patients with cirrhosis. N Engl J Med 1996, 334:693-699.
37. Yoshikakawa J, Matsui O, Takashima T, et al. Fatty metamorphosis in hepatocellular carcinoma: Radiologic features in 10 cases. Am J Roentgenol 1988, 151:717-720.
38. Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. Am J Roentgenol 1990, 154:509-514.
39. Kim CK, Lim JH, Lee WJ Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001, 20:47-55.
40. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT and MR and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001, 25:327-336.
41. Kim CK, Lim JH, Lee WJ Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001, 20:99-104.
42. Farinati F, Gianni S. Surveillance for hepatocellular carcinoma in cirrhosis: Is it cost effective?. Eur J Cancer Prev 2001, 10:111-115.
43. Miller WJ, Baron RL, Dodd GD, et al. Malignancies in patients with cirrhosis: CT sensitivity in and specificity in 200 consecutive transplant patients. Radiology 1994, 193:645-650.
44. Petersin MS, Baron RL, Marsh JW, et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT based tumor detection rate in 430 cases with surgical and pathologic correlation. Radiology 2000, 217:743-749.
45. Lim JH, Kim CK, Lee WJ, et al. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. Am J Roentgenol 2000, 175:693-698.
46. Jang HJ, Lim JH, Lee SJ, et al. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?. Radiology 2000, 215:373.
47. Taourel PG, Pageaux GP, Coste V, et al. Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil. Radiology 1995, 197:377-380.
48. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996, 200:79-84.
49. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001, 219:445-454.
50. Ebara M, Fukada H, Kojima Y, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999, 210:81-88.
51. Ward J, Robinson PJ How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002, 12:2258-2272.
52. Halvaara J, Tervahartiala P, Isoniemi H, Hockerstadt K. Efficacy of sequential use of superparamagnetic iron oxide and gadolinium in liver MR imaging. Acta Radiol 2002, 43:180-185.
53. Wong LK, Link DP, Frey CF Fibrolamellar hepatocarcinoma: Radiology, management and pathology. AJR Am J Roentgenol 1982, 139:172-175.
54. Adam A, Gibson RN, Soreide O, et al. The radiology of fibrolamellar hepatoma. Clin Radiol 1986, 37:355-358.
55. Brandt DJ, Johnson CD, Stephens DH, Weiland LH Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 1988, 151:295-299.
56. Ichikawa T, Federle MP, Grazioli L, et al. Fibrolamellar hepatocellular carcinoma: Imaging and pathologic findings in 31 recent cases. Radiology 1999, 213:352-361.
57. Freeny PC, Baron RL, Teefey SA Hepatocellular carcinoma: Reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology 1992, 182:143-148.
58. McLarney JK, Rucker PT, Bender GN, et al. Fibrolamellar carcinoma of the liver: Radiologic-pathologic correlation. Radiographics 1999, 19:453-471.
59. Soyer P, Roch A, Levesque M, Legmann P. CT of fibrolamellar hepatocellular carcinoma. J Comput Assist Tomogr 1991, 14:533-538.
60. Corrigan K, Semelka RC Dynamic contrast enhanced MR imaging of the fibrolamellar hepatocellular carcinoma. Abdom Imag 1995, 20:122-125.
61. Mattison GR, Glazer GM, Quint LE, et al. MR imaging of hepatic focal nodular hyperplasia: Characterization and distinction from primary malignant hepatic tumors. AJR Am J Roentgenol 1987, 148:711-715.
62. Wibulpolprasert B, Dhiensiri T. Peripheral cholangiocarcinoma: Sonographic evaluation. J Clin Ultrasound 1992, 20:303-314.
63. Choi BI, Park JH, Kim YI, et al. Peripheral cholangiocarcinoma and clonorchiasis: CT findings. Radiology 1988, 169:149-153.
64. Lacomis JM, Baron RL, Oliver JH, et al. Cholangiocarcinoma: Delayed CT contrast enhancement patterns. Radiology 1997, 2003:98-104.
65. Fan ZM, Yamashita Y, Harada M, et al. Intrahepatic cholangiocarcinoma: Spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 1993, 161:313-317.
66. Mortele KJ, Ros PR Cystic focal liver lesions in the adult: Differential CT and MR imaging features. Radiographics 2001, 21:895-910.
67. Devaney K, Goodman ZD, Ishak KG Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994, 18:1078-1091.
68. Korobkin M, Stephens DH, Lee JK, et al. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol 1989, 153:507-511.
69. Buetow PC, Buck JL, Pantongrag-Brown L, et al. Biliary cystadenoma and cystadenocarcinoma: Clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995, 196:805-810.
70. Shirkhoda A, Ros PR, Farah J, et al. Lymphoma of the solid abdominal viscera. Radiol Clin North Am 1990, 28:785-799.
71. Ginaldi S, Bernardino M, Jing B, et al. Ultrasonographic patterns of hepatic lymphoma. Radiology 1980, 136:427-431.
72. Sanders LM, Botet JF, Straus DJ, et al. CT of primary lymphoma of the liver. AJR 1989, 152:973-976.
73. Levy DW, Rindsberg S, Friedman AC, et al. Thorotrast-induced hepatosplenic neoplasia: CT identification. AJR Am J Roentgenol 1986, 146:997-1004.
74. Naka N, Ohsawa M, Tomita Y, et al. Angiosarcoma in Japan. A review of 99 cases. Cancer 1995, 75:989-996.
75. Buetow PC, Buck JL, Ros PR, et al. Malignant vascular tumors of the liver: Radiologic-pathologic correlation. Radiographics 1994, 14:153-166.
76. Powers C, Ros PR, Stoupis C, et al. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 1994, 14:459-482.
77. Makhlouf HR, Ishak KG, Goodman ZD Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999, 85:562-582.
78. Ishak KG, Sesterham IA, Goodman MZD, et al. Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases. Hum Pathol 1994, 15:839-852.
79. Radin DR, Craig JR, Colletti PM, et al. Hepatic epithelioid hemangioendothelioma. Radiology 1988, 169:145-148.
80. Furui S, Itai Y, Ohtomo K, et al. Hepatic epithelioid hemangioendothelioma: report of five cases. Radiology 1989, 171:63-68.
81. Miller WJ, Dodd GD, Federle MP, Baron RL Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 1992, 159:53-57.
82. Van Beers B, Roche A, Mathieu D, et al. Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr 1992, 16:420-424.
83. Bartolozzi C, Cioni D, Donati F, et al. Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 2001, 11:1374-1388.
84. Harbin WP, Robert NJ, Ferrucci JT Diagnosis of cirrhosis based on regional changes in hepatic morphology: Radiological and pathologic analysis. Radiology 1980, 135:273.
85. Ito K, Mitchell DG, Gabata T Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 1999, 211:723-726.
86. Takayasu K, Yoshie K, Muramatsu Y, et al. Haemodynamic changes in non-alcoholic (viral) liver cirrhosis studied by computed tomography (CT) arterial portography and CT arteriography. J Gastroenterol Hepatol 1999, 14:908-914.
87. Ohtomo K, Baron RL, Dodd GD, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993, 188:31-35.
88. Ohtomo K, Baron RL, Dodd GD, et al. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993, 189:871-874.
89. Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993. National Institutes of Health Consensus Development Conference Statement.
90. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991, 22:172-178.
91. Karahan OI, Dodd GD, Chintapalli KN, et al. Gastrointestinal wall thickening in patients with cirrhosis: frequency and patterns at contrast-enhanced CT. Radiology 2000, 215:103-107.
92. Chopra S, Dodd GD, Chintapalli KN, et al. Mesenteric, omental, and retroperitoneal edema in cirrhosis: frequency and spectrum of CT findings. Radiology 1999, 211:737-742.
93. Bonkovsky HL, Slaker DP, Bills EB, et al. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990, 99:1079-1091.
94. Siegelman ES, Mitchell DG, Semelka RC Abdominal iron deposition: Metabolism, MR findings and clinical importance. Radiology 1996, 199:13.
95. Jensen PD, Jensen FT, Christensen T, Ellegaard J Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994, 87:171-184.
96. Bonkovsky HL, Rubin RB, Cable EE, et al. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 1999, 212:227-234.
97. Eugene RS, Michael FS, Willis CM Schiffs diseases of the liver 2002, Lippincott Williams & Wilkins, Baltimore. 9th edn.
98. Dixon A, Walsche J. Computed tomography of the liver in Wilson's disease. J Comput Assist Tomogr 1984, 8:46-48.
99. Ko S, Lee T, Ng S, et al. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl. Abdom Imag 1998, 23:56-59.
100. Piekarski J, Goldberg HI, Royal SA, et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980, 137:727-729.
101. Alpern MB, Lawson TL, Foley WD, et al. Focal hepatic mass and fatty infiltration detected by enhanced dynamic CT. Radiology 1986, 158:45.
102. Siegelman ES, Outwater EK, Vinitski S, et al. Fat suppression by saturation/opposed phase hybrid technique: Spin-echo versus gradient-echo imaging. Magn Reson Imaging 1995, 13:545-548.
103. Mitchell DG, Nazarian LN Hepatic vascular diseases: CT and MRI. Semin Ultrasound, CT, MR 1995, 16:49-68.
104. Soyer P, Rabenandrasana A, Barge J, et al. MRI of Budd-Chiari syndrome. Abdom Imag 1994, 19:325-329.
105. Stark DD, Hahn PF, Trey C, et al. MRI of the Budd-Chiari syndrome. AJR Am J Roentgenol 1986, 146:1141-1148.
106. Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand 1977, 202:289-293.
107. Warshauer DM, Lee JK Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 2004, 182:15-28.
108. Kessler A, Mitchell DG, Israel HL, Goldberg BB Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imag 1993, 18:159-163.
109. Brunt EM, Tiniakos DG Metabolic storage diseases: amyloidosis. Clin Liver Dis 2004, 8:915-930.
110. Jacobs JE, Birnbaum BA, Furth EE Abdominal visceral calcification in primary amyloidosis: CT findings. Abdom Imag 1997, 22:519-521.
111. Benson, Hemmingsson A, Ericsson A, et al. Magnetic resonance imaging in primary amyloidosis. Acta Radiol 1987, 28:13-15.
112. Barnes PF, Decock KM, Reynolds TN, et al. A comparison of amebic and pyogenic abscess of the liver. Medicine 1987, 66:472-483.
113. Mortele KJ, Segatto E, Ros PR The infected liver: radiologic-pathologic correlation. Radiographics 2004, 24:937-955.
114. Ralls PW Inflammatory disease of the liver. Clin Liver Dis 2002, 6:203-225.
115. Ralls PW, Barnes PF, Radin DR, et al. Sonographic features of amebic and pyogenic abscesses: A blinded comparison. Am J Roentgenol 1987, 149:499-501.
116. Radin DR, Ralls PW, Colletti PM, Halls JM CT of amebic liver abscess. Am J Roentgenol 1988, 150:1297-1301.
117. Metser U, Haider MA, Dill-Macky M, et al. Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT. Radiology 2005, 235:97-105.
118. Semelka RC, Kelekis NL, Sallah S, et al. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. Am J Roentgenol 1997, 169:1311-1316.
119. Pastakia B, Shawker TH, Thaler M, et al. Hepatosplenic candidiasis: wheels within wheels. Radiology 1988, 166:417-444.
120. Pedrosa I, Saiz A, Arrazola J, et al. Hydatid disease: radiologic and pathologic features and complications. Radiographics 2000, 20:795-817.
121. Beggs I. The radiology of hydatid disease. Am J Roentgenol 1985, 145:639-648.
122. Kalovidouris A, Gouliamos A, Vlachos L, et al. MRI of abdominal hydatid disease. Abdom Imag 1994, 19:489-494.
123. Cesmeli E, Vogelaers D, Voet D, et al. Ultrasound and CT of liver parenchyma in acute schistosomiasis. Br J Radiol 1997, 70:758-760.
124. Patel SA, Castillo DF, Hibbeln JF, Watkins JL Magnetic resonance imaging appearance of hepatic schistosomiasis, with ultrasound and computed tomography correlation. Am J Gastroenterol 1993, 88:113-116.
125. Martin DR Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imag 2002, 13:151-164.